Want to jump right to here next time? Bookmark: www.canpku.org/education/understanding/ucd

Understanding Urea Cycle Disorders (UCDs)

Urea Cycle Disorders (UCDs) are a group of rare genetic conditions that affect how the body removes ammonia. Ammonia is a toxic byproduct created when the body breaks down protein. In a healthy urea cycle (primarily in the liver), ammonia is converted into urea so it can be safely eliminated.

In someone with a UCD, one enzyme or transporter in the urea cycle does not work well enough, so ammonia can build up in the blood. Because ammonia can affect the brain and nervous system, early recognition and ongoing clinic follow-up are important.

Important: UCDs are not one single condition. There are several related urea-cycle and urea-cycle-related disorders, and management depends on the specific subtype. Your metabolic clinic will confirm the subtype and guide a plan.

What is it?

A Urea Cycle Disorder (UCD) is a genetic condition a person is born with. Some people are diagnosed through newborn screening, while others are diagnosed later in childhood or adulthood. UCDs vary in severity, and individuals can have different symptom patterns and different management needs.

Common terms:
UCD - Urea Cycle Disorder
OTC - Ornithine transcarbamylase deficiency (the most common UCD; typically X-linked)
CPS1 - Carbamoyl phosphate synthetase 1 deficiency
CIT1/ASS1 - Argininosuccinate synthetase deficiency (Citrullinemia Type 1)
ASL - Argininosuccinate lyase deficiency (sometimes referred to as ASA in community materials)
ARG1 - Arginase-1 deficiency (sometimes written as ARG)
NAGS - N-acetylglutamate synthase deficiency
HHH - Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
Citrin deficiency - A urea-cycle-related transporter disorder (sometimes described as Citrullinemia Type 2 / adult citrin deficiency)

Key ideas:
UCDs affect the bodys ability to remove ammonia.
Ammonia can rise quickly during illness or stress for some people, so clinic guidance matters.
Many individuals and families live well with UCDs with the right plan and regular follow-up.

Why early detection matters

Many infants with a severe UCD can appear healthy at birth. Early detection helps families and healthcare teams act before ammonia becomes dangerously elevated. This is one reason newborn screening can be so important.

It is also important to know that not all UCDs are reliably detected by current newborn screening tests, and screening panels can differ across Canada. If you have concerns about symptoms, family history, or screening coverage where you live, your metabolic clinic or healthcare team can guide next steps.

Living with UCDs

Lifelong condition:
UCDs are genetic conditions, and many people manage them throughout life with the support of a metabolic clinic and care team. Some individuals remain stable for long periods, while others may need closer monitoring or additional supports.

What builds up:
The key concern in UCDs is ammonia. When the urea cycle is not working well enough, ammonia can accumulate and may affect the brain and nervous system.

Crisis overview (high-level):
Some people with UCDs can be at risk of sudden worsening (often described as a hyperammonemic episode). Your metabolic clinic can explain what this means for your specific UCD subtype and what warning signs matter most for you or your child.

Why management matters:
Management aims to keep ammonia levels in a safe range and support development, learning, and overall well-being. Plans can include nutrition strategies, medical foods, supplements, and medications depending on the person and subtype.

Monitoring and labs:
Clinics may use lab monitoring (including ammonia and related markers) to understand how the body is doing and to guide care over time. Your clinic will explain the schedule and what results mean for your situation.

Important: Tracking methods can differ by clinic and by disorder (exchanges vs grams vs total protein vs formula rules). Always follow your clinics plan and ask if you are unsure.

Tools

For practical nutrition support, visit Nourish. For medication and treatment options, visit Therapies for UCDs.

Learn more

If you are looking for more background or diagnosis information, these resources may help.

Have a resource you think belongs here? Email website@canpku.org with the link or file and a short description.

Canada - medication snapshot

This is a higher level review of medications available in Canada currently for UCDs. Some people with UCDs use medications that help reduce ammonia (often called nitrogen scavengers), along with nutrition strategies and supplements. Which medications are used depends on the specific UCD, age, medical history, and your clinics plan.

Examples families may hear about include:
sodium phenylbutyrate products (brand names can vary)
glycerol phenylbutyrate products (brand names can vary)
sodium benzoate (in some treatment plans)
amino acid supplements such as citrulline or arginine (condition-dependent)

Availability and coverage can vary by province and situation. For the most up-to-date details, visit Therapies for UCDs and confirm recommendations with your metabolic clinic.

Helpful links - external support and education

External links are shared for community support and education. CanPKU+ does not control external content. Always confirm medical guidance with your metabolic clinic.

Images

View urea cycle images and diagrams

Urea Cycle Diagram

Metabolism - what happens in the body

Credit: Horizon Therapeutics

UCD Onset Graphic

UCD symptoms can appear in newborns, children, or adults.

Credit: Rare Diseases Canada
(Data from NIH Rare Disease Clinical Research Network)

UCD Relationship Graphic

Urea Cycle Disorders include several related genetic conditions.

Credit: FLOK

Brief overview of the different UCDs

UCDs are related, but they are not all the same. They affect different steps in the urea cycle or related transport processes, so symptoms, severity, and management can vary. These short summaries are only a general introduction. Your metabolic clinic can explain what is most relevant for your specific diagnosis.

OTC - Ornithine transcarbamylase deficiency

OTC deficiency is the most common UCD. It affects a step in the urea cycle that helps the body process ammonia. It is usually inherited in an X-linked pattern, which means symptoms can vary widely. Some people become very sick in infancy, while others are diagnosed later in childhood or adulthood.

CPS1 - Carbamoyl phosphate synthetase 1 deficiency

CPS1 deficiency affects one of the first steps of the urea cycle. Because this step is so important for removing ammonia, severe forms can present very early in life. Some milder or partial forms may be recognized later. Management focuses on preventing ammonia buildup and responding quickly if levels rise.

CIT1 / ASS1 - Argininosuccinate synthetase deficiency (Citrullinemia Type 1)

This disorder affects the ASS1 enzyme in the urea cycle. People with this condition often have high citrulline on testing, which is why the name citrullinemia is used. Severity can vary. Some people present in infancy with significant hyperammonemia, while others may have later-onset or less severe forms.

ASL - Argininosuccinate lyase deficiency

ASL deficiency affects the next step after ASS1 in the urea cycle. It is sometimes called argininosuccinic aciduria or referred to as ASA in community materials. Along with ammonia-related concerns, some people may also have other health considerations that need follow-up over time. Management is individualized and guided by the metabolic clinic.

ARG1 - Arginase-1 deficiency

ARG1 deficiency affects the last step of the urea cycle. It is sometimes written as ARG. Compared with some other UCDs, it may present differently and may be more strongly associated with gradual neurological or movement-related changes over time, although ammonia can still be part of the picture. Ongoing monitoring remains important.

NAGS - N-acetylglutamate synthase deficiency

NAGS deficiency affects a helper step that the urea cycle needs in order to start working properly. Because of that, ammonia can rise when this signal is missing. It is one of the UCDs where diagnosis is especially important because the treatment approach can differ from some of the other subtypes.

HHH - Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome

HHH syndrome is a urea-cycle-related disorder that affects transport rather than a classic enzyme step. The long name describes some of the lab features seen in this condition. Like other UCDs, it can interfere with ammonia handling, but it has its own pattern and needs individualized management.

Citrin deficiency - a urea-cycle-related transporter disorder

Citrin deficiency is a transporter disorder that can affect how the body handles certain metabolic pathways related to the urea cycle. It is sometimes described as Citrullinemia Type 2 or adult citrin deficiency, depending on age and presentation. It is related to the broader UCD category, but its symptoms and management pattern can differ from the more classic enzyme-based UCDs.

Tip: These summaries are meant to help explain the names and basic differences. They are not a substitute for subtype-specific guidance from your metabolic clinic.

Sources and references

Where do you want to go next?

If you are looking for treatment options used in Canada, start here:

Therapies for UCDs UCD Registry

Or explore practical food and nutrition support:

Nourish Flourish Life Stages